Proxy Votes Now

Home › Funds › GMO › GMO Emerging Markets Fund

GMO Emerging Markets Fund (GEMEX) proxy voting record 2025-2026

Fund family: GMO · Filed by GMO TRUST (CIK 772129) · SEC series S000004911

Share classes and tickers: GEMEX (C000213363), GEMMX (C000013272), GEMNX (C000213362), GEMVX (C000013271), GMEFX (C000013270), GMEMX (C000013268), GMOEX (C000013269)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,266 with, 4 against, 36 abstentions (not counted as with management); 116 items carried no recommendation. Shareholder proposals: 13 FOR, 8 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with GMO as a whole

The same two figures as GMO’s manager page (51,210 ballot items across 26 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsGMOItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)78.2%1,54491.3%40,970
Backed environmental and social shareholder proposals at US companiesn/a010.3%369

Where this fund voted differently from most GMO funds

Each ballot item this fund voted is set against the votes of the other GMO funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most GMO funds on all 1,490 items where a comparison was possible.

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Corporate Governance8080
Director Elections7904
Capital Structure3760
Compensation2080
Audit-related1600
Other400
Extraordinary Transactions290
Other Social Issues60
Shareholder Rights and Defenses40
Environment or Climate10

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
CEMEX SAB de CVMarch 26, 2026$6M350
Alibaba Group Holding LimitedSeptember 25, 2025$5M70
KB Financial Group, Inc.March 26, 2026$176,805110

Notable votes against management

MeetingCompanyProposalFundMgmt
September 9, 2025GMO U.S. Treasury FundElection of Trustees: Paul BravermanForAgainst
September 9, 2025GMO U.S. Treasury FundElection of Trustees: Peter TufanoForAgainst

Search this fund’s votes by company

2,422 ballot items at 252 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, GMO Emerging Markets Fund (GEMEX) voted at 252 shareholder meetings of 209 companies, on 2,422 ballot items in all. Where management made a recommendation, the fund followed it on 98.3% of the items and voted against it 4 times. Its most frequent area of disagreement was director elections (4 of its votes against management). It voted on 21 shareholder proposals. It voted FOR the board's own proposals less often than GMO's funds as a whole (78.2% against 91.3%). It voted the same way as most GMO funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of GMO’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.